| Publication date | Communities | Collections | Article title | Author(s) | Journal/Conference |
|---|---|---|---|---|---|
| 12 Mar 2019 | BMRC | Institute of Molecular and Cell Biology | Physicochemical characterization and phase I study of CMAB008, an infliximab biosimilar produced by a different expression system | Qing An, Yingxin Zheng, Yirong Zhao, Tao Liu, Huaizu Guo, Dapeng Zhang, Weizhu Qian, Hao Wang, Yajun Guo, Sheng Hou, Jing Li | Drug Design, Development and Therapy |
| 28 Nov 2017 | BMRC | Institute of Molecular and Cell Biology | Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses | Boning Liu, Huaizu Guo, Jin Xu, Ting Qin, Qingcheng Guo, Nana Gu, Dapeng Zhang, Weizhu Qian, Jianxin Dai, Sheng Hou, Hao Wang, Yajun Guo | mAbs |